Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ ]f1
{n
J"FC%\|
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£©
IVW1]y
5K?}}Frrt`
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© #h@J=Ki
\Y}3cE
1.Co-stimulators (or co-stimulating molecules) 3 LdQ]S
fJWC)E
2.NK-kB CX m+)a-L
Y\0}R,]a-
3.Immunoglobulin superfamily z
;u
/>j';6vi
4.antigen-presenting cell (APC) !*`-iQo&
]
7 _`]7p
5.death domain !'Q -yoHKD
WF\)fc#;_o
6.CCR and CXCR KeNL0_Pw
^3hn0DVQ
7.Lectin (or mitogen) HD N9.5S
6 K-5g/hL
8.Clusters of differentiation, CD) nbG/c80
. <tq61
9.B7 family hkOsm6
2On_'^O
10.Cytotoxic T lymphocyte, CTL) P4T h_B7
G7=pBf
11.IL-15 and IL-15 receptor (IL-15R) 9!><<7TS
#6!
5 2
12.MHC restriction j:w{;(1=W
3~#h|?
13.Affinity-chromatography a
{ab*tM
,j 5&6X=1M
14.Cyctosprin A, CsA w}{5#
XW?b\!@ $
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) "6a8s;
vLxQ *50v$
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© Ys!>+nL|
kPjd_8z2n
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 zX#%{#9
bZx!0>
h
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ +I>p !v
`nO71mo
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ JH7Ad (:
KgW:@X7wvM
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© pN\Vr8tJ
3Oa*%kP+
ÃâÒßѧרҵ£º "G:<7oTa
7E!7"2e
a
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ *MI*Rz?4
3DaQo
0N
Ïû»¯ÄÚ¿Æ£º "S&%w8V
VGqa)ri"
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ _p?s9&
5(
_6+'0
ѪҺ²¡Ñ§×¨Òµ£º A>VX*xd
h3gWOU
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿